TCD and Merion ink research deal

MERION PHARMACEUTICALS has joined forces for research with Trinity College, Dublin in aN agreement worth €110,000 for the first year.

This figure may grow over the years as the research is expected to be conducted over several years by Trinity College Immunology researchers and focus on the area of oral vaccine.

The research aims to establish key proofs to Merrion’s patented technologies in the area of oral vaccine delivery.

Dr Ed Lavelle of the TCD School of Immunology and Biochemistry will head the research.